SM
Sabby Management Portfolio holdings
AUM
$13M
This Quarter Return
-0.87%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$27.3M
AUM Growth
+$27.3M
(-23%)
Cap. Flow
-$16M
Cap. Flow
% of AUM
-58.69%
Top 10 Holdings %
Top 10 Hldgs %
63.39%
Holding
90
New
12
Increased
13
Reduced
21
Closed
28
Top Buys
| 1 |
SPDR Gold Trust
GLD
|
$5.37M |
| 2 |
Traws Pharma
TRAW
|
$3.04M |
| 3 |
NBRV
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
|
$1.37M |
| 4 |
BPTH
Bio-Path Holdings Inc
BPTH
|
$986K |
| 5 |
TOP Ships
TOPS
|
$476K |
Top Sells
| 1 |
Benitec Biopharma
BNTC
|
$6.36M |
| 2 |
NURO
NeuroMetrix, Inc. Common Stock
NURO
|
$3.75M |
| 3 |
TEUM
Pareteum Corporation
TEUM
|
$2.9M |
| 4 |
CorMedix
CRMD
|
$1.59M |
| 5 |
RDGT
Ridgetech, Inc. Ordinary Shares
RDGT
|
$1.59M |
Sector Composition
| 1 | Healthcare | 70.93% |
| 2 | Industrials | 2.44% |
| 3 | Technology | 0.62% |
| 4 | Consumer Discretionary | 0.11% |
| 5 | Materials | 0.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
SPDR Gold Trust
GLD
$107B
| $5.37M | 1.49% | +37,550 | New | +$5.37M |
|
|
2
Traws Pharma
TRAW
$9.89M
| $3.35M | 0.93% | 8,741,243 +7,938,397 | +989% | +$3.04M |
|
|
ODT
3
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $1.75M | 0.48% | 53,839 -39,015 | -42% | -$1.27M |
|
|
NBRV
4
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $1.37M | 0.38% | +1,035,667 | New | +$1.37M |
|
|
GNCA
5
DELISTED
Genocea Biosciences, Inc.
GNCA
| $1.11M | 0.31% | 538,359 +61,008 | +13% | +$126K |
|
|
HIND
6
Vyome Holdings, Inc. Common Stock
HIND
$243M
| $1.08M | 0.3% | 570,418 -115,243 | -17% | -$219K |
|
|
BPTH
7
DELISTED
Bio-Path Holdings Inc
BPTH
| $986K | 0.27% | +123,346 | New | +$986K |
|
|
PAVMZ
8
DELISTED
PAVmed Inc. Series Z Warrant
PAVMZ
| $836K | 0.23% | 2,152,719 -811,910 | -27% | -$315K |
|
9
Microbot Medical
MBOT
$185M
| $773K | 0.21% | 76,000 -7,333 | -9% | -$74.6K |
|
10
Actinium Pharmaceuticals
ATNM
$55.5M
| $713K | 0.2% | 3,275,718 -5,521,791 | -63% | -$1.2M |
|
|
11
TOP Ships
TOPS
$26M
| $639K | 0.18% | 799,212 +594,985 | +291% | +$476K |
|
|
12
Benitec Biopharma
BNTC
$348M
| $603K | 0.17% | 118,285 -1,247,330 | -91% | -$6.36M |
|
|
PHAS
13
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
| $576K | 0.16% | 94,351 -30,437 | -24% | -$186K |
|
|
AMRN
14
Amarin Corp
AMRN
$311M
| $575K | 0.16% | 26,810 -4,180 | -13% | -$89.6K |
|
15
Plus Therapeutics
PSTV
$45.3M
| $562K | 0.16% | 234,124 +120,524 | +106% | +$289K |
|
|
NMTR
16
DELISTED
9 Meters Biopharma, Inc. Common Stock
NMTR
| $525K | 0.15% | 941,586 -307,228 | -25% | -$171K |
|
17
CervoMed
CRVO
$83.7M
| $500K | 0.14% | 1,085,446 +617,627 | +132% | +$285K |
|
|
GHSI
18
DELISTED
Guardion Health Sciences, Inc. Common Stock
GHSI
| $439K | 0.12% | +1,993,929 | New | +$439K |
|
19
Pulmatrix
PULM
$18M
| $384K | 0.11% | 446,749 -611,933 | -58% | -$526K |
|
20
Xenetic Biosciences
XBIO
$4.4M
| $382K | 0.11% | 265,498 -139,052 | -34% | -$200K |
|
21
Palisade Bio
PALI
$6.3M
| $378K | 0.1% | 381,487 +176,664 | +86% | +$175K |
|
22
Theriva Biologics
TOVX
$3.94M
| $348K | 0.1% | 687,304 -148,155 | -18% | -$75K |
|
|
XBIOW
23
DELISTED
Xenetic Biosciences, Inc. Warrants
XBIOW
| $297K | 0.08% | 216,789 -50,000 | -19% | -$68.5K |
|
|
AIM
24
AIM ImmunoTech Inc.
AIM
$6.64M
| $288K | 0.08% | 528,811 +343,640 | +186% | +$187K |
|
|
CYTO
25
DELISTED
Altamira Therapeutics Ltd. Common Shares 0.01 SF (Bermuda)
CYTO
| $278K | 0.08% | 171,883 +4,383 | +3% | +$7.09K |
|